FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
about
Cyclosporin versus tacrolimus for liver transplanted patientsFeeding an army: The metabolism of T cells in activation, anergy, and exhaustionInhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin ACross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.Bifurcated converging pathways for high Ca2+- and TGFbeta-induced inhibition of growth of normal human keratinocytesDesign and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.Disorders associated with acute rapid and severe bone loss.The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction.T cell responses in calcineurin A alpha-deficient mice.Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.Nonsteroid immune modulators and bone disease.Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation.Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels.Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer.Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.[Progress of CypA and lung cancer-related research].Tacrolimus in cardiac transplantation.GM1485, a nonimmunosuppressive immunophilin ligand, promotes neurofunctional improvement and neural regeneration following stroke.Post-surgical irradiation causes cellular immune suppression in patients with breast cancer.Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus neoformans.Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production.The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.Effects of FK506 on long-term potentiation observed by optical imaging in organotypic hippocampal slice cultureSingle center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus
P2860
Q24244114-1F95E5B6-FC6E-4963-B35B-C8324226BDB1Q28085624-01880E7A-5CCF-414A-BBA1-6D2363629818Q28368142-5EF36C85-28D3-4B43-997D-7768A7C8F06CQ33932993-5970534E-177B-4A7F-AF76-65AD1E371B3BQ34000499-7F952737-86AB-4B48-A5D5-AA5686D482A0Q34583529-EDE5857B-9943-48C4-AADF-1367808D720CQ35606552-E0785353-EE64-469C-9B04-A012043DFAEDQ36362769-969F76FB-BC9C-49D5-B9D1-945BC25A392DQ36366258-00F3D010-6A26-4A75-A893-436740C2D059Q36530398-3E98A784-ADC0-445B-84C2-CF91F14CD685Q36532542-FD4AA3F8-11F3-43F0-93EF-EDCDBE095053Q36619363-E16FFDCD-9D53-4DF7-BCF8-A2A8B9C46E59Q36694835-3BE1D898-22EE-4940-99F6-728C150F186DQ36898984-46D29AC0-2231-4592-9FE1-CF8CE1B88A00Q40172570-B7F94F41-BE3F-4ABB-BCB6-3D6944878EDDQ42939494-083B3CD7-C1F3-4CAD-BA9B-ACDD8ECC0FCAQ43061682-C8551005-559D-4306-8CB8-AB4E19EC668CQ45803565-5116417A-972D-4710-BD72-6B0E4A40B00CQ46010642-C9CF19F8-332B-4206-87A2-EFA878187049Q47300999-363197C4-A3F3-442D-A395-E1EF7755D316Q50267679-1955646E-3289-4722-8A8B-8AA6D1C389FAQ54188491-CBB1F8F1-7977-4D3A-9475-69AB9FDA6AB2Q55080447-78B53C13-EDAF-4831-ABB1-B3007835469CQ57991513-F5138FE7-BBE3-40EF-8609-421A4E70C2E5Q58204824-142C10DC-806A-40DC-8C7E-24C04D98BE02
P2860
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@ast
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@en
type
label
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@ast
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@en
prefLabel
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@ast
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@en
P1476
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
@en
P2093
Siekierka JJ
P304
P356
10.1016/0952-7915(92)90024-9
P577
1992-10-01T00:00:00Z